INTS - INTENSITY THERAPEUTICS, INC.
7.52
-0.060 -0.798%
Share volume: 41,302
Last Updated: 03-03-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.31%
PREVIOUS CLOSE
CHG
CHG%
$7.58
-0.06
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-13-2024 | 03-13-2025 | 05-13-2025 | 11-06-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | ||||
| Operating expenses | 4.743 M | 5.069 M | 3.570 M | 3.203 M | 3.394 M | 2.733 M | |
| Selling general and admin | 1.928 M | 1.506 M | 1.419 M | 1.236 M | 1.205 M | 1.180 M | |
| Research and development | 2.815 M | 3.563 M | 2.151 M | 1.967 M | 2.189 M | 1.553 M | |
| Total expenses | 4.743 M | 5.069 M | 3.570 M | 3.203 M | 3.394 M | 2.733 M | |
| 6.87% | -29.57% | -10.28% | 5.96% | -19.48% | |||
| Operating income | -4.743 M | -5.069 M | -3.570 M | -3.203 M | -3.394 M | -2.733 M | |
| Ebit | -4.743 M | -5.069 M | -3.561 M | -3.209 M | -3.362 M | -2.730 M | |
| Pretax income | -4.603 M | -4.971 M | -3.513 M | -3.181 M | -3.347 M | -2.671 M | |
| 7.99% | -29.33% | -9.45% | 5.22% | -20.20% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -4.603 M | -4.971 M | -3.513 M | -3.181 M | -3.347 M | -2.671 M | |
| -7.99% | 29.33% | 9.45% | -5.22% | 20.20% |